J&J (JNJ) Q2 Earnings & Sales Top, EPS View Cut on M&A Costs

Johnson & Johnson’s (JNJ) second-quarter 2024 earnings came in at $2.82 per share, which beat the Zacks Consensus Estimate of$ 2.71. Earnings rose 10.2% from the year-ago period.Adjusted earnings exclude intangible amortization and some other special items. Including these items, J&J reported second-quarter earnings of $1.93 per share, down 5.9% year over year.Sales of this drug and medical devices giant came in at$ 22.45 billion, which beat the Zacks Consensus Estimate of $22.38 billion. Sales rose 4.3% fr ...